Clinical Trial Update: Trial of CF101 to Treat Patients With Psoriasis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial for CF101 in plaque psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• CF101 (piclidenoson)

Snippet

Sponsor: Can-Fite BioPharma | Conditions: Plaque Psoriasis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-09-20